Skip to content

Evaluation of A New Digestive Reconstruction Procedure Following Pancreatoduodenectomy

Evaluation of a Modified Procedure of Digestive Tract Reconstruction Following Pancreatoduodenectomy: A Multicenter Randomized Controlled Study

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01931449
Enrollment
200
Registered
2013-08-29
Start date
2014-01-31
Completion date
2015-07-31
Last updated
2013-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer, Periampullary Carcinoma

Keywords

Pancreatoduodenectomy, Digestive Tract Reconstruction, Pancreas

Brief summary

The purpose of this study is to evaluate the validity and safety of a modified operative procedure of digestive tract reconstruction following pancreatoduodenectomy which enables the pancreatic juice and bile to bypass at the pancreatointestinal anastomosis and merge at gastrointestinal anastomosis. It is anticipated that this procedure can decrease the risk of post-surgical pancreatic leakage and preserve the patients' digestive function as well.

Detailed description

Pancreatoduodenectomy (PD) is one of the most complicated surgeries in abdominal clinical practice. It is widely used in the treatment of pancreatic head carcinoma, periampullary carcinoma, chronic pancreatitis with intractable pain, pancreatic head mass which unable to rule out pancreatic cancer. PD was improved in many ways in the last 80 years and the post-surgical mortality has decreased under 5%. Since the resected region of PD is wide including gall bladder, billiary tract, duodenum, pancreas, stomach, jejunum and regional lymph nodes. It has a high prevalence of complications, of which pancreatic leakage is the most common and serious one with a prevalence rate of 5-25% and mortality rate 20-50%。 The objective of the present study is to evaluate a new surgical procedure used for the digestive tract reconstruction following PD. The new procedure enables the pancreatic juice and bile to bypass at the pancreatointestinal anastomosis and merge at gastrointestinal anastomosis which can decrease the risk of post-surgical pancreatic leakage and keep the digestive function of patients. A multicenter, randomized, controlled study is designed to observe the prevalence of pancreatic leakage, other post-surgical complications, hospital stay, medical costs, life quality and other indexes to evaluate the efficacy and safety of this procedure. It is anticipated that through the study, this new procedure can be systematically verified if it is an ideal procedure of digestive reconstruction following PD which can be promoted into wider use.

Interventions

PROCEDUREModified method of digestive tract reconstruction
PROCEDURERoutine digestive tract reconstruction

Sponsors

Southwest Hospital, China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Below 80 years old * CT (Computed Tomography), CTA (Computed Tomographic Angiography), MRI (Magnetic Resonance Imaging) or ultrasonic test suggested pancreatic head carcinoma, periampullary carcinoma, chronic pancreatitis with intractable pain, pancreatic head mass which unable to rule out pancreatic cancer, with or without obstructive jaundice/chronic abdominal pain.

Exclusion criteria

* Liver Metastasis * Metastasis in common bile duct and hepatic duct * Extensive lymph node metastasis, metastasis at hepatic portal or above pancreas * Pancreatic head or periampullary has tight adhesion with postcava or aorta * Distant metastasis * Poor physical condition to tolerate anesthesia and surgery (e.g. severe cardio-pulmonary diseases, blood coagulation disorders)

Design outcomes

Primary

MeasureTime frame
Incidence of Pancreatic Leakageup to 12 months

Secondary

MeasureTime frame
Life Quality Scoreup to 12 months
Amylase Test of Abdominal Drainage Fluidup to 3 months

Other

MeasureTime frame
Anesthesia Scoreup to 12 months
Length of Hospital Stayup to 12 months
Re-surgery Rateup to 12 months

Countries

China

Contacts

Primary ContactHuai-zhi Wang, M.D., Ph.D.
whuaizhi@gmail.com86-23-13996950719

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026